Insider Transactions in Q3 2025 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2025
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
191
-0.7%
|
$764
$4.37 P/Share
|
|
Jul 22
2025
|
Kristin Abate Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
238
-2.45%
|
$952
$4.0 P/Share
|